BRAF and melanoma: First, global hypomethylation induced by or associated with the NRASQ61 driver mutation was identified as a common feature in melanoma (similar to what Hou and colleagues demonstrated for BRAF V600E signaling), potentially playing an important role in the disease pathogenesis [24,136].